Bruce J. Aronow

39.1k total citations · 4 hit papers
334 papers, 23.5k citations indexed

About

Bruce J. Aronow is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Bruce J. Aronow has authored 334 papers receiving a total of 23.5k indexed citations (citations by other indexed papers that have themselves been cited), including 205 papers in Molecular Biology, 65 papers in Immunology and 51 papers in Oncology. Recurrent topics in Bruce J. Aronow's work include Clusterin in disease pathology (22 papers), Renal and related cancers (19 papers) and Bioinformatics and Genomic Networks (19 papers). Bruce J. Aronow is often cited by papers focused on Clusterin in disease pathology (22 papers), Renal and related cancers (19 papers) and Bioinformatics and Genomic Networks (19 papers). Bruce J. Aronow collaborates with scholars based in United States, Australia and Japan. Bruce J. Aronow's co-authors include Anil G. Jegga, Jing Chen, Eric E. Bardes, Jeffery D. Molkentin, David P. Witte, Judith A.K. Harmony, S. Steven Potter, Chi V. Dang, Kathryn A. O’Donnell and Karen Zeller and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

Bruce J. Aronow

323 papers receiving 23.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

ToppGene Suite for gene list enrichment analysis and candidate gene prioritization

2009 2.0k citations Eric E. Bardes, Bruce J. Aronow et al. profile →
Genetic lineage tracing defines myofibroblast origin and function in the injured heart

2016 640 citations Bruce J. Aronow et al. Nature Communications profile →
Blockade of Chronic Type I Interferon Signaling to Control Persistent LCMV Infection

2013 548 citations Elizabeth Wilson, Douglas H. Yamada et al. Science profile →
The Pan-ErbB Negative Regulator Lrig1 Is an Intestinal Stem Cell Marker that Functions as a Tumor Suppressor

2012 528 citations Bruce J. Aronow et al. profile →

Peers

Countries citing papers authored by Bruce J. Aronow

Since Specialization

Citations

This map shows the geographic impact of Bruce J. Aronow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bruce J. Aronow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bruce J. Aronow more than expected).

Fields of papers citing papers by Bruce J. Aronow

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bruce J. Aronow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bruce J. Aronow. The network helps show where Bruce J. Aronow may publish in the future.

Co-authorship network of co-authors of Bruce J. Aronow

This figure shows the co-authorship network connecting the top 25 collaborators of Bruce J. Aronow. A scholar is included among the top collaborators of Bruce J. Aronow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bruce J. Aronow. Bruce J. Aronow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Bering: joint cell segmentation and annotation for spatial transcriptomics with transferred graph embeddings 2025 ·Nature Communications ·Kang Jin, (unknown), Ke Zhang, (unknown), (unknown), Jian Tang, Bruce J. Aronow, (unknown)	0
2	Deep learning-based multimodal spatial transcriptomics analysis for cancer 2024 ·Advances in cancer research ·(unknown), Bruce J. Aronow, V. B. Surya Prasath	10
3	An interactive single cell web portal identifies gene and cell networks in COVID-19 host responses 2021 ·iScience ·Kang Jin, Eric E. Bardes, Alexis Mitelpunkt, (unknown), Surbhi Bhatnagar, Soma Sengupta, Daniel Pomeranz Krummel, Marc E. Rothenberg, Bruce J. Aronow	12
4	Electronic health record and patterns of care for children with cerebral palsy 2021 ·Developmental Medicine & Child Neurology ·Brad G. Kurowski, (unknown), Amy F. Bailes, Janet Zahner, Jilda Vargus‐Adams, Mary McMahon, Bruce J. Aronow, Alexis Mitelpunkt	6
5	Expression Profiling of Fibroblasts in Chronic and Acute Disease Models Reveals Novel Pathways in Kidney Fibrosis 2018 ·Journal of the American Society of Nephrology ·Atsuko Y. Higashi, Bruce J. Aronow, Gregory R. Dressler	31
6	Glioma Subtypes Clustering Method using Histopathological Image Analysis 2018 ·(unknown), Hiroharu Kawanaka, V. B. Surya Prasath, Bruce J. Aronow, Shinji Tsuruoka	2
7	miR-196b target screen reveals mechanisms maintaining leukemia stemness with therapeutic potential 2018 ·The Journal of Experimental Medicine ·Sara E. Meyer, David E. Muench, Andrew M. Rogers, (unknown), (unknown), Eric O’Brien, John P. Perentesis, John G. Doench, Ashish Lal, Patrick J. Morris, Craig J. Thomas, Judy Lieberman, Edwina McGlinn, Bruce J. Aronow, Nathan Salomonis, H. Leighton Grimes	20
8	mTOR kinase inhibition reduces tissue factor expression and growth of pancreatic neuroendocrine tumors 2018 ·Journal of Thrombosis and Haemostasis ·(unknown), Hala Elnakat Thomas, (unknown), (unknown), (unknown), (unknown), (unknown), Yohei Hisada, H W Davis, Xiaoyang Qi, Carol A. Mercer, Fred V. Lucas, Bruce J. Aronow, Nigel Mackman, Henri H. Versteeg, Vladimir Y. Bogdanov	11
9	Blockade of Chronic Type I Interferon Signaling to Control Persistent LCMV Infection breakdown → 2013 ·Science ·Elizabeth Wilson, Douglas H. Yamada, Heidi Elsaesser, Jonathan Herskovitz, Jane C. Deng, Genhong Cheng, Bruce J. Aronow, Christopher L. Karp, David G. Brooks	548
10	Ras-Driven Transcriptome Analysis Identifies Aurora Kinase A as a Potential Malignant Peripheral Nerve Sheath Tumor Therapeutic Target 2012 ·Clinical Cancer Research ·Ami V. Patel, David Eaves, Walter J. Jessen, Tilat A. Rizvi, Jeffrey Ecsedy, Mark G. Qian, Bruce J. Aronow, John P. Perentesis, Eduard Serra, Timothy P. Cripe, Shyra J. Miller, Nancy Ratner	47
11	Selective stimulation of IL-4 receptor on smooth muscle induces airway hyperresponsiveness in mice 2011 ·The Journal of Experimental Medicine ·Charles Perkins, Noriko Yanase, (unknown), Lucy A. Gildea, Tatyana Orekov, Crystal Potter, Frank Brombacher, Bruce J. Aronow, Marsha Wills‐Karp, Fred D. Finkelman	66
12	Gene Expression Analysis Identifies Potential Biomarkers of Neurofibromatosis Type 1 Including Adrenomedullin 2010 ·Clinical Cancer Research ·Trent R. Hummel, Walter J. Jessen, Shyra J. Miller, Lan Kluwe, Victor F. Mautner, Margaret R. Wallace, Conxi Lázaro, Grier P. Page, Paul Worley, Bruce J. Aronow, Elizabeth K. Schorry, Nancy Ratner	37
13	Credentialing a Preclinical Mouse Model of Alveolar Rhabdomyosarcoma 2009 ·Cancer Research ·Koichi Nishijo, Qingrong Chen, Lei Zhang, Amanda T. McCleish, (unknown), Min Jung Cho, Suresh I. Prajapati, Jonathan Gelfond, Gary B. Chisholm, Joel Michalek, Bruce J. Aronow, Frederic G. Barr, R. Lor Randall, Marc Ladanyi, Stephen J. Qualman, Brian P. Rubin, Robin D. LeGallo, Chiayeng Wang, Javed Khan, Charles Keller	66
14	The SWI/SNF ATPase Brm Is a Gatekeeper of Proliferative Control in Prostate Cancer 2008 ·Cancer Research ·Hui Shen, (unknown), Nitin Saini, Clay E.S. Comstock, Ankur Sharma, Katherine Weaver, Mónica P. Revelo, William L. Gerald, Erin Williams, Walter J. Jessen, Bruce J. Aronow, Gary B. Rosson, Bernard E. Weissman, Christian Muchardt, Moshé Yaniv, Karen E. Knudsen	58
15	Activator Protein-1 Transcription Factors Are Associated with Progression and Recurrence of Prostate Cancer 2008 ·Cancer Research ·Xuesong Ouyang, Walter J. Jessen, Hikmat Al‐Ahmadie, Angel M. Serio, (unknown), (unknown), Victor E. Reuter, Peter T. Scardino, Michael M. Shen, Bruce J. Aronow, Andrew J. Vickers, William L. Gerald, Cory Abate‐Shen	108
16	Prolonged Exposure to Reduced Levels of Androgen Accelerates Prostate Cancer Progression in Nkx3.1; Pten Mutant Mice 2007 ·Cancer Research ·Whitney Banach‐Petrosky, Walter J. Jessen, Xuesong Ouyang, Hui Gao, Jayashree Rao, (unknown), Bruce J. Aronow, Cory Abate‐Shen	62
17	Genomics in Endocrinology 2007 ·Humana Press eBooks ·Stuart Handwerger, Bruce J. Aronow	2
18	Large-Scale Molecular Comparison of Human Schwann Cells to Malignant Peripheral Nerve Sheath Tumor Cell Lines and Tissues 2006 ·Cancer Research ·Shyra J. Miller, Fatima Rangwala, Jon Williams, Peter Ackerman, Sue Kong, Anil G. Jegga, Sérgio Kaiser, Bruce J. Aronow, Silke Frahm, Lan Kluwe, Victor Mautner, Meena Upadhyaya, David Muir, Margaret R. Wallace, Jussara Hagen, Dawn E. Quelle, Mark A. Watson, Arie Perry, David H. Gutmann, Nancy Ratner	158
19	Transcriptional response to persistent β ₂ -adrenergic receptor signaling reveals regulation of phospholamban, which alters airway contractility 2006 ·Physiological Genomics ·Dennis W. McGraw, (unknown), Sue Kong, Augusto A. Litonjua, Evangelia G. Kranias, Bruce J. Aronow, Stephen B. Liggett	19
20	A Central Role for a Single c-Myb Binding Site in a Thymic Locus Control Region 1995 ·Molecular and Cellular Biology ·Kevin C. Ess, (unknown), Gregory J. Cost, David P. Witte, John J. Hutton, Bruce J. Aronow	34

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact